ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors. It is necessary that ctDNA test results are linked to clinical outcomes in order to demonstrate clinical validity for recurrence detection and explore its value in a healthcare environment subject to cost containment.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek powyżej 18 lat
- •Leczenie raka prowadzone z zamiarem całkowitego wyleczenia
- •Plan regularnych wizyt kontrolnych zgodnie ze standardową opieką
- •Pisemna zgoda na udział w badaniu
- •Chęć dzielenia się anonimowymi danymi medycznymi z badaczami
- •Możliwość pobrania próbek krwi przy zapisaniu i na kolejnych wizytach przez 3 lata
- •Co najmniej jedna próbka krwi pobrana 3-12 tygodni po operacji lub chemioterapii
- •Potwierdzony histologicznie nowotwór z wymienionych typów i stopni zaawansowania
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (57)
University of Alabama at Birmingham
Birmingham, United States
Ironwood Cancer & Research Centers
Chandler, United States
Genesis Cancer Center
Hot Springs, United States
University of California, San Diego
La Jolla, United States
Hoag Memorial Hospital Presbyterian
Newport Beach, United States
Redwood City
Redwood City, United States
Sutter Institute for Medical Research
Sacramento, United States
University of Colorado
Aurora, United States
Memorial Healthcare System
Hollywood, United States
The Oncology Institute of Hope & Innovation
Lakeland, United States
Tulane Cancer Center
New Orleans, United States
Christus Highland/ Boniol
Shreveport, United States
Central Maine Medical Center
Lewiston, United States
Massachusetts General Hospital
Boston, United States
Cancer & Hematology Centers of Western Michigan
Grand Rapids, United States
Mayo Clinic (Rochester)
Rochester, United States
Astera Cancer Care
East Brunswick, United States
Icahn School of Medicine at Mount Sinai
New York, United States
UNC- Chapel Hill
Chapel Hill, United States
The Christ Hospital Cancer Center
Cincinnati, United States
Cleveland Clinic
Cleveland, United States
Toledo Clinic Cancer Center
Toledo, United States
Crozer-Keystone Health System
Broomall, United States
University of Pennsylvania
Philadelphia, United States
WellSpan Medical Oncology & Hematology at York Cancer Center
York, United States
Carolina Urologic Research Center
Myrtle Beach, United States
Carolina Blood and Cancer Care Associates
Rock Hill, United States
UT Southwestern Medical Center
Dallas, United States
DHR Health Advance Care Center
Edinburg, United States
The Center for Cancer and Blood Disorders
Forth Worth, United States
The University of Texas Health Science Center at San Antonio
San Antonio, United States
Utah Cancer Specialists
Salt Lake City, United States
ThedaCare Regional Cancer Center
Appleton, United States
CHU Besançon
Besançon, France
Hôpital Franco-Britannique
Levallois-Perret, France
Institut Paoli-Calmettes
Marseille, France
Ambroise Paré-Hartmann
Neuilly, France
APHP Tenon Hospital - Sorbonne
Paris, France
Asklepios Klinik Altona
Hamburg, Germany
SLK-Kliniken Heilbronn GmbH
Heilbronn, Germany
Ludwig Maximilian University Munich
Munich, Germany
Instituto Romagnolo per lo Studio dei Tumori "Dino Amadori" IRCCS IRST, SrL
Meldola, Italy
Azienda USL-IRCCS di Reggio Emilia
Reggio Emilia, Italy
Policlinico Universitario Agostino Gemelli
Roma, Italy
Hospital Teresa Herrera (C.H.U.A.C)
A Coruña, Spain
Vall Hebron Institute of Oncology
Barcelona, Spain
Hospital Clinic of Barcelona
Barcelona, Spain
ICO Institut Catala d'Oncologia
Barcelona, Spain
Instituto Catalan de Oncologia de Girona
Girona, Spain
Hospital Universitario Insular de Gran Canaria
Las Palmas de Gran Canaria, Spain
Hospital San Carlos
Madrid, Spain
Hospital Universitario La Paz
Madrid, Spain
CIOSS HM Sanchinarro
Madrid, Spain
Hospital Universitario Virgen de la Victoria
Málaga, Spain
CCS Hospital Universitari Parc Taulí
Sabadell, Spain
Hospital Clinico de Santiago de Compostela
Santiago de Compostela, Spain
Hospital Clínico de Valencia
Valencia, Spain
Trial contact
Clinical Trial Operations
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.